Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients
Clinical trial NCT06991712 · RECRUITING
Trial details
- NCT number
- NCT06991712
- Sponsor
- Christopher Kai Shun Leung
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-19
- Primary completion
- 2025-12-31
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.